Aldehyde dehydrogenase (ALDH) inhibitor disulfiram was among four cancer selective inhibitors identified blocking the growth of cultured TMPRSS2-ERG fusion positive VCaP cells at nanomolar concentration as well as reducing VCaP xenograft growth in vivo[2]. Here, TMPRSS2 is linked to cancer.